Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of chronic delta hepatitis with peglylated interferon.

Trial Profile

Treatment of chronic delta hepatitis with peglylated interferon.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 May 2014

At a glance

  • Drugs Peginterferon alfa-2a (Primary)
  • Indications Hepatitis D
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2012 Planned end date changed from 1 May 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
    • 21 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 18 May 2010 Planned end date changed from 1 May 2010 to 1 May 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top